Diabetes Drug, Actos, May Lead to Bladder Cancer
Diabetes Drug, Actos, May Lead to Bladder Cancer As the FDA warns that taking the diabetes medication Actos (pioglitazone) may increase the risk of bladder cancer, Ennis and Ennis P.A. continues to investigate potential claims. (PRWEB) August 01, 2011 On June 15, 2011, the U.S. Food and Drug Administration (FDA) required added warnings on the label of the diabetes medication Actos (pioglitazone), which is manufactured by Takeda Pharmaceuticals, stating that it may increase the risk of bladder cancer when taken for more than one year, reports Ennis & Ennis, P.A. This warning came sho
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 308
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4